The three-way interactions between the hypothalamic-pituitary-adrenal and gonadal axes and the immune system.
暂无分享,去创建一个
[1] M. Dallman,et al. Corticosterone acts on the brain to inhibit adrenalectomy-induced adrenocorticotropin secretion. , 1988, Endocrinology.
[2] M. Merino,et al. Presence of immunoreactive corticotropin releasing hormone in thyroid lesions. , 1994, The American journal of pathology.
[3] Schürmeyer Th. On the relationship between ACTH and cortisol secretion. , 1987 .
[4] S. Al-Damluji,et al. Adrenergic mechanisms in the control of corticotrophin secretion. , 1988, The Journal of endocrinology.
[5] G. Chrousos,et al. Increased plasma concentrations, hypothalamic content, and in vitro release of arginine vasopressin in inflammatory disease-prone, hypothalamic corticotropin-releasing hormone-deficient Lewis rats. , 1992, Endocrinology.
[6] E. D. de Kloet,et al. The influence of ovarian steroids on hypothalamic-pituitary-adrenal regulation in the female rat. , 1995, The Journal of endocrinology.
[7] D. Orth. Corticotropin-releasing hormone in humans. , 1992, Endocrine reviews.
[8] C. Tsigos,et al. Physiology of the hypothalamic-pituitary-adrenal axis in health and dysregulation in psychiatric and autoimmune disorders. , 1994, Endocrinology and metabolism clinics of North America.
[9] G. Chrousos,et al. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. , 1995, The New England journal of medicine.
[10] N. Barden,et al. Estrogen-induced decrease of glucocorticoid receptor messenger ribonucleic acid concentration in rat anterior pituitary gland. , 1987, Molecular endocrinology.
[11] G. Kingsley,et al. Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis. , 1992, Arthritis and rheumatism.
[12] G. Chrousos,et al. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis. , 1992, JAMA.
[13] D. Boumpas,et al. Glucocorticoid Therapy for Immune-Mediated Diseases: Basic and Clinical Correlates , 1993, Annals of Internal Medicine.
[14] A. Baum,et al. Sex differences in sensitivity of the hypothalamic-pituitary-adrenal axis. , 1993, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.
[15] G. Chrousos,et al. Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. , 1991, Science.
[16] M. Ferin,et al. The hypothalamic control of the menstrual cycle and the role of endogenous opioid peptides. , 1984, Recent progress in hormone research.
[17] D. Torpy,et al. Alprazolam blocks the naloxone-stimulated hypothalamo-pituitary-adrenal axis in man. , 1993, The Journal of clinical endocrinology and metabolism.
[18] C. Nemeroff,et al. Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims. , 1988, Archives of general psychiatry.
[19] B. Robinson,et al. Glucocorticoid stimulates expression of corticotropin-releasing hormone gene in human placenta. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[20] F. Rose. The Control of the hypothalamo-pituitary-adrenocortical axis , 1989 .
[21] H. Imura,et al. Effects of adrenalectomy and dexamethasone administration on the level of prepro-corticotropin-releasing factor messenger ribonucleic acid (mRNA) in the hypothalamus and adrenocorticotropin/beta-lipotropin precursor mRNA in the pituitary in rats. , 1985, Endocrinology.
[22] D. Jezova,et al. Repeated stress-induced activation of corticotropin-releasing factor neurons enhances vasopressin stores and colocalization with corticotropin-releasing factor in the median eminence of rats. , 1991, Neuroendocrinology.
[23] M. Whitnall. Stress selectively activates the vasopressin-containing subset of corticotropin-releasing hormone neurons. , 1989, Neuroendocrinology.
[24] E. van Cauter,et al. Effects of "jet lag" on hormonal patterns. I. Procedures, variations in total plasma proteins, and disruption of adrenocorticotropin-cortisol periodicity. , 1981, The Journal of clinical endocrinology and metabolism.
[25] L. Swanson,et al. The organization of noradrenergic pathways from the brainstem to the paraventricular and supraoptic nuclei in the rat , 1982, Brain Research Reviews.
[26] A. Grossman,et al. Alpha-adrenergic stimulation of corticotropin secretion by a specific central mechanism in man. , 1987, Neuroendocrinology.
[27] R. Handa,et al. Gonadal Steroid Hormone Receptors and Sex Differences in the Hypothalamo-Pituitary-Adrenal Axis , 1994, Hormones and Behavior.
[28] W. Vale,et al. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin , 1981 .
[29] T. Suda,et al. Inhibitory effect of adrenocorticotropin on corticotropin- releasing factor release from rat hypothalamus in vitro. , 1986, Endocrinology.
[30] S. Mccann,et al. Ultrashort-loop positive feedback of corticotropin (ACTH)-releasing factor to enhance ACTH release in stress. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[31] M. Dallman,et al. Chronic streptozotocin diabetes in rats facilitates the acute stress response without altering pituitary or adrenal responsiveness to secretagogues. , 1991, Endocrinology.
[32] F. Antoni. Vasopressinergic Control of Pituitary Adrenocorticotropin Secretion Comes of Age , 1993, Frontiers in Neuroendocrinology.
[33] J. Doppman,et al. Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome. , 1991, The New England journal of medicine.
[34] A. Iranmanesh,et al. Intensive venous sampling paradigms disclose high frequency adrenocorticotropin release episodes in normal men. , 1990, The Journal of clinical endocrinology and metabolism.
[35] W. Vale,et al. Arginine vasopressin potentiates adrenocorticotropin release induced by ovine corticotropin-releasing factor. , 1984, The Journal of clinical investigation.
[36] A. F. Muller,et al. RU 486: a steroid with antiglucocorticosteroid activity that only disinhibits the human pituitary-adrenal system at a specific time of day. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[37] A. Grossman,et al. Corticotropin-releasing hormone in health and disease: an update. , 1992, Acta endocrinologica.
[38] B. Allolio,et al. The hypothalamic-pituitary-adrenal axis in critical illness: response to dexamethasone and corticotropin-releasing hormone. , 1993, The Journal of clinical endocrinology and metabolism.
[39] Guy Hoffman,et al. Estradiol enhances leukocyte binding to tumor necrosis factor (TNF)-stimulated endothelial cells via an increase in TNF-induced adhesion molecules E-selectin, intercellular adhesion molecule type 1, and vascular cell adhesion molecule type 1. , 1994, The Journal of clinical investigation.
[40] R. Ekman,et al. Reduced concentrations of galanin, arginine vasopressin, neuropeptide Y and peptide YY in the temporal cortex but not in the hypothalamus of brains from schizophrenics , 1991, Acta psychiatrica Scandinavica.
[41] H SELYE,et al. [General adaptation syndrome and diseases of adaptation]. , 1946, L'union medicale du Canada.
[42] J W Funder,et al. Studies of the secretion of corticotropin-releasing factor and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep. I. Effect of an audiovisual stimulus and insulin-induced hypoglycemia. , 1989, Neuroendocrinology.
[43] G. Chrousos,et al. Hormonal regulation of human corticotropin-releasing hormone gene expression: implications for the stress response and immune/inflammatory reaction. , 1994, Endocrine reviews.
[44] I. Clarke,et al. Glucocorticoids regulate ovine hypophysial portal levels of corticotropin-releasing factor and arginine vasopressin in a stress-specific manner. , 1989, Endocrinology.
[45] G. Chrousos,et al. Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans. , 1995, The Journal of clinical investigation.
[46] G. Chrousos,et al. Local secretion of corticotropin-releasing hormone in the joints of Lewis rats with inflammatory arthritis. , 1992, The Journal of clinical investigation.
[47] G. Chrousos,et al. Immune corticotropin-releasing hormone is present in the eyes of and promotes experimental autoimmune uveoretinitis in rodents. , 1995, Endocrinology.
[48] J. I. Kitay,et al. Adrenocortical function in the hamster. Sex differences and effects of gonadal hormones. , 1970, Endocrinology.
[49] S. George,et al. Gonadal regulation of corticotropin-releasing factor immunoreactivity in hypothalamus , 1988, Brain Research Bulletin.
[50] D. Blatter,et al. Sex hormonal effects on the severity of streptococcal cell wall-induced polyarthritis in the rat. , 1983, Arthritis and rheumatism.
[51] W. Pardridge,et al. Receptor-mediated peptide transport through the blood-brain barrier. , 1986, Endocrine reviews.
[52] J. Amsterdam,et al. Assessment of adrenal gland volume by computed tomography in depressed patients and healthy volunteers: A pilot study , 1987, Psychiatry Research.
[53] M. Dallman,et al. Corticosteroid inhibition of ACTH secretion. , 1984, Endocrine reviews.
[54] A. Grossman,et al. Differential effects of opiate peptides and alkaloids on anterior pituitary hormone secretion. , 1983, Neuroendocrinology.
[55] P. Plotsky,et al. Pathways to the Secretion of Adrenocorticotropin: A View from the Portal * , 1991, Journal of neuroendocrinology.
[56] R. Zoeller,et al. Corticotropin releasing hormone mRNA is elevated on the afternoon of proestrus in the parvocellular paraventricular nuclei of the female rat. , 1990, Brain research. Molecular brain research.
[57] F. Goodwin,et al. Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress (2) , 1988, The New England journal of medicine.
[58] I. Clarke,et al. Corticotropin-release inhibitory factor Evidence for dual stimulatory and inhibitory hypothalamic regulation over adrenocorticotropin secretion and biosynthesis , 1994, Trends in Endocrinology & Metabolism.
[59] S. Pillemer,et al. Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia. , 1994, Arthritis and rheumatism.
[60] B. McEwen,et al. Adrenal steroid receptors and actions in the nervous system. , 1986, Physiological reviews.
[61] R L Wilder,et al. Neuroendocrine-immune system interactions and autoimmunity. , 1995, Annual review of immunology.
[62] B. B. Turner,et al. Sex differences in the binding of Type I and type II corticosteroid receptors in rat hippocampus , 1992, Brain Research.
[63] W. Cowan,et al. Direct hypothalamo-autonomic connections , 1976, Brain Research.
[64] R. Williams,et al. Williams Textbook of endocrinology , 1985 .
[65] A. Lewy,et al. Circadian rhythm abnormalities in totally blind people: incidence and clinical significance. , 1992, The Journal of clinical endocrinology and metabolism.
[66] G. Chrousos,et al. The pituitary corticotroph is not the rate limiting step in the postoperative recovery of the hypothalamic-pituitary-adrenal axis in patients with Cushing syndrome. , 1993, The Journal of clinical endocrinology and metabolism.
[67] G. Chrousos,et al. Glucocorticoid and/or glucocorticoid antagonist effects in inflammatory disease-susceptible Lewis rats and inflammatory disease-resistant Fischer rats. , 1995, Endocrinology.
[68] K. Catt,et al. Magnocellular axons in passage through the median eminence release vasopressin , 1986, Nature.
[69] N. Ekhator,et al. Serial cerebrospinal fluid corticotropin-releasing hormone concentrations in healthy and depressed humans. , 1992, The Journal of clinical endocrinology and metabolism.
[70] G. Chrousos,et al. Multiple feedback regulatory loops upon rat hypothalamic corticotropin-releasing hormone secretion. Potential clinical implications. , 1988, The Journal of clinical investigation.
[71] C. Oliver,et al. Insulin-induced hypoglycemia stimulates corticotropin-releasing factor and arginine vasopressin secretion into hypophysial portal blood of conscious, unrestrained rams. , 1990, The Journal of clinical investigation.
[72] N. Holbrook,et al. Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. , 1984, Endocrine reviews.
[73] G. Kroemer,et al. Immunoendocrine communication via the hypothalamo-pituitary-adrenal axis in autoimmune diseases. , 1993, Endocrine reviews.
[74] S. Makino,et al. Corticotropin-releasing hormone and pituitary-adrenocortical responses in chronically stressed rats , 1988, Regulatory Peptides.
[75] K. Federlin,et al. Adrenal secretion of cortisol in patients with rheumatoid arthritis. , 1990, The Journal of rheumatology.
[76] G. Chrousos,et al. Neurotransmitter-induced hypothalamic-pituitary-adrenal axis responsiveness is defective in inflammatory disease-susceptible Lewis rats: in vivo and in vitro studies suggesting globally defective hypothalamic secretion of corticotropin-releasing hormone. , 1992, Neuroendocrinology.
[77] G. Chrousos,et al. Exercise-induced activation of the hypothalamic-pituitary-adrenal axis: marked differences in the sensitivity to glucocorticoid suppression. , 1994, The Journal of clinical endocrinology and metabolism.
[78] A. Steinberg,et al. Modulation of the expression of murine lupus by gonadotropin-releasing hormone analogs. , 1994, Endocrinology.
[79] F. Bloom,et al. Corticotropin-releasing factor and behavior. , 1985, Federation proceedings.
[80] K. Catt,et al. Mechanisms of action of corticotropin-releasing factor and other regulators of corticotropin release in rat pituitary cells. , 1983, The Journal of biological chemistry.
[81] S. Foote,et al. Corticotropin-releasing hormone increases tonic but not sensory-evoked activity of noradrenergic locus coeruleus neurons in unanesthetized rats , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[82] B. Canny,et al. Distinct classes of corticotropes mediate corticotropin-releasing hormone- and arginine vasopressin-stimulated adrenocorticotropin release. , 1991, Endocrinology.
[83] R. Post,et al. Psychiatric implications of basic and clinical studies with corticotropin-releasing factor. , 1984, The American journal of psychiatry.
[84] E. Remmers,et al. Corticotropin-releasing hormone in synovial fluids and tissues of patients with rheumatoid arthritis and osteoarthritis. , 1993, Journal of immunology.
[85] H. Besedovsky,et al. Network of immune-neuroendocrine interactions. , 1977, Clinical and experimental immunology.
[86] B. McEwen,et al. Adaptation of the hypothalamic-pituitary-adrenal axis to chronic ethanol stress. , 1990, Neuroendocrinology.
[87] S. Lightman,et al. Stress and the hypothalamo-pituitary-adrenal axis: acute, chronic and immunological activation. , 1992, The Journal of endocrinology.
[88] B. B. Turner,et al. Sex difference in glucocorticoid binding in rat pituitary is estrogen dependent. , 1990, Life sciences.
[89] J. Funder,et al. Effect of AVP on susceptibility of ovine pituitary cells to a cytotoxic analogue of CRF. , 1991, The American journal of physiology.
[90] S. Cummings,et al. Corticotropin-releasing factor immunoreactivity is widely distributed within the central nervous system of the rat: an immunohistochemical study , 1983, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[91] C. Craddock. Corticosteroid-induced lymphopenia, immunosuppression, and body defense. , 1978, Annals of internal medicine.
[92] G. Chrousos,et al. Human corticotropin-releasing factor in man: pharmacokinetic properties and dose-response of plasma adrenocorticotropin and cortisol secretion. , 1984, The Journal of clinical endocrinology and metabolism.
[93] G. Chrousos,et al. Ovine corticotropin-releasing factor administration in normal men. Pituitary and adrenal responses in the morning and evening. , 1985, Hormone research.
[94] J. Seckl,et al. Atriopeptin: an endogenous corticotropin-release inhibiting hormone. , 1992, Endocrinology.
[95] B. Carroll,et al. A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility. , 1981, Archives of general psychiatry.
[96] B Stein,et al. Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta , 1995, Molecular and cellular biology.
[97] E. R. Kloet,et al. Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. , 1985, Endocrinology.
[98] K. Krishnan,et al. Pituitary size in depression. , 1991, The Journal of clinical endocrinology and metabolism.
[99] E. Redei,et al. Corticotropin release-inhibiting factor is preprothyrotropin-releasing hormone-(178-199). , 1995, Endocrinology.
[100] C. Edwards,et al. Localisation of 11 beta-hydroxysteroid dehydrogenase--tissue specific protector of the mineralocorticoid receptor. , 1988, Lancet.
[101] D. Pfaff,et al. Absence of oestradiol concentration in cell nuclei of LHRH-immunoreactive neurones , 1983, Nature.
[102] K. Catt,et al. Phorbol 12-myristate 13-acetate and vasopressin potentiate the effect of corticotropin-releasing factor on cyclic AMP production in rat anterior pituitary cells. Mechanisms of action. , 1987, The Journal of biological chemistry.